The fertility testing devices market is expected to witness substantial growth by 2027 owing to mounting prevalence of damaging lifestyle habits, including drinking, smoking, and poor diet. Additionally, escalating incidences of infertility issues in both males and females around the world is estimated to fuel market growth through the forecast period.

Fertility testing devices refer to convenient and non-invasive solutions that help track the ovulation window as well as the menstruation cycle. These devices provide information regarding the appropriate ovulation window to help couples conceive and birth a child naturally. Prominent R&D activities to design accurate and convenient fertility testing devices have propelled industry uptake in recent years.

Moreover, key industry players are focusing on product development to cater to emerging consumer requirements, which has positively impacted the overall business landscape. For instance, in June 2021, Fertility Focus Limited, a leading manufacturer of fertility tracking devices, launched its novel skin-worn fertility monitoring sensor, dubbed OvuFirst, which has been designed to help women conceive naturally.

OvuFirst helps women keep track of their ovulation cycle by monitoring their skin temperature. It is a clinically proven and non-invasive sensor that confirms a woman’s fertile window with 90% precision even during irregular periods.

The fertility testing devices market has been categorized based on purchase mode, product type, gender, end user, and region. In terms of product type, the market has further been bifurcated into fertility monitors, ovulation prediction kits, and male fertility test kits.

The fertility monitors sub-segment is anticipated to expand at a CAGR of approximately 6.6% over the forecast period. Fertility monitors have emerged as one of the convenient ways to track fertile days accurately at home, which is set to support segmental growth in the coming years.

Based on purchase mode, the market been divided into prescription and OTC. In 2020, the fertility testing devices market from the OTC sub-segment was valued at over USD 467 million and is slated to progress at a robust pace over 2021-2027. Growing popularity of OTC mode as an affordable and convenient method for couples to get information regarding their fertility issues is likely to boost segmental growth.

By gender, the fertility testing devices market has been segmented into female and male. The female sub-segment amassed a revenue of more than USD 522 million in 2020 and is predicted to register a steady CAGR over the study period propelled by rising incidences of delayed first pregnancy in women.

With respect to end user, the market has been classified into fertility clinics & hospitals, home care settings, and others. The home care settings sub-segment is projected to garner significant gains by 2027, registering around 6.4% CAGR over the assessment timeline. Fertility testing devices are used in home care settings as they can be operated without professional guidance, which is set to bolster market adoption through the forthcoming years.

From the regional perspective, the Latin America fertility testing devices market surpassed a valuation of USD 49 million in 2020 and is expected to gain considerable traction over the review period.